5 Most Promising Small-Cap Stocks According to Analysts

4. Korro Bio, Inc. (NASDAQ:KRRO)

Latest Average Analyst Share Price Target: $116.67

Latest Share Price Percentage Upside: 130.98%

Korro Bio, Inc. (NASDAQ:KRRO) is a small biotechnology company that is developing gene editing medicines. Its shares are rated Buy on average and the average analyst share price target is $116.67. It’s also a relatively new entrant on the stock market, as the shares were made available for trading in November 2023 after a private placement of $117 million. Since then, the shares have gained a respectable 226% on the market.